|
|
Volumn 12, Issue 2, 2005, Pages 71-72
|
|
Targeted therapy: The fast pace of progress
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
BEVACIZUMAB;
CETUXIMAB;
CYTOSTATIC AGENT;
IMATINIB;
MONOCLONAL ANTIBODY;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BLOOD BRAIN BARRIER;
BREAST CANCER;
CANCER GROWTH;
CANCER LOCALIZATION;
CANCER SURVIVAL;
CANCER THERAPY;
CHEMOTHERAPY;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG ACTIVITY;
EDITORIAL;
GASTROINTESTINAL STROMAL TUMOR;
GENETIC DISORDER;
HEMATOLOGIC MALIGNANCY;
HUMAN;
MULTIPLE MYELOMA;
|
|
EID: 18444404330
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: 10.1177/107327480501200201 Document Type: Editorial |
|
Times cited : (3)
|
|
References (3)
|
